Adipex

In recent years, a growing global concern has been obesity. Patients with obesity are at major risk for developing several diseases. These diseases may significantly impact patients' daily lives and increase the mortality rate [1]. Over a year, medication for obesity has undergone substantial changes. An amphetamine-like prescription drug called Phentermine (Adipex-P, Lomaira) appetite. In the last few years, Phentermine and its derivatives have attracted much attention due to their use in weight reduction; by reducing appetite or prolonging the feeling of fullness, it can aid in weight reduction...

BACKGROUND: Chitoglucan (CG) is a bioactive component obtained from Flammulina velutipes Sing, an edible mushroom, which is known to have an anti-obesity effect. However, its biological and hormonal activities in alleviating obesity through regulation of adipocyte-derived proteins have not been examined yet. PURPOSE: The present study aimed to investigate the anti-obesity effects of chitoglucan and its hormonal mechanisms in high-fat diet (HFD)-induced mice. METHODS: The mice were fed either a normal diet (Normal group) or a high fat diet (HFD group) over 6 weeks...

No abstract text is available yet for this article.

No abstract text is available yet for this article.

Obesity is a global epidemic that contributes to a number of health complications including cardiovascular disease, type 2 diabetes, cancer and neuropsychiatric disorders. Pharmacotherapeutic strategies to treat obesity are urgently needed. Research over the past two decades has increased substantially our knowledge of central and peripheral mechanisms underlying homeostatic energy balance. Homeostatic mechanisms involve multiple components including neuronal circuits, some originating in hypothalamus and brain stem, as well as peripherally-derived satiety, hunger and adiposity signals that modulate neural activity and regulate eating behavior...

No abstract text is available yet for this article.

No abstract text is available yet for this article.

In 16 obese patients, the effect of beta-amino-isobutyl-benzol as polysterol-sulfonate on free fatty acids, triglycerides and i.v. GTT was compaired with that of a placebo. The question was to be answered if beta-amino-isobutyl-benzol worsens the GTT and if the lipolytic effect outranges lipolysis during fasting. No statistically significant change of the GTT, free fatty acids and triglycerides could be found between the beta-amino-isobutyl-benzol period and the placebo period.